The overall objective is to identify, prioritize and evaluate multi-modal blood and neuroimaging biomarkers that have diagnostic potential for prediction and monitoring psychotic disorders and associated metabolic co-morbidities. The consortium brings together clinicians, researchers and industry partners in the domains of psychiatry, neuroimaging, metabolic research, systems biology and bioinformatics.

The 4-year EU-project is coordinated by Research Professor Matej Orešič from VTT Technical Research Centre of Finland. Total budget for the project is € 5.94 million €, of which the EU's share is € 4.23 million.